Dyne Therapeutics DYN
NASDAQ DYN
$16.21 -0.13 (-0.80%)
At close: Sep 29, 2026 · 4:00 PM EDT

Dyne Therapeutics (DYN) Operating Expenses (2019 - 2026)

Updated

Dyne Therapeutics' Operating Expenses came in at $181.66 million for Q2 2026, up 56.9% from $115.79 million a year earlier and up 45.0% from the prior quarter.

Analysis

Dyne Therapeutics (DYN) Operating Expenses (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Dyne Therapeutics reported Operating Expenses of $536.96 million, up 21.8% year-over-year; for FY2025, it came in at $468.18 million, up 36.1% from FY2024.

  • Operating Expenses has increased in each of the last six years, with a five-year compound annual growth rate of 51.5% (FY2020 to FY2025).
  • Going back by year, Operating Expenses was $343.89 million in FY2024 (+42.0%), $242.16 million in FY2023 (+41.6%), $170.96 million in FY2022 (+14.0%) and $150.03 million in FY2021 (+155.8%).
  • The Q2 2026 figure represents the highest quarterly Operating Expenses in data going back to Q3 2019.
  • Year-over-year, Operating Expenses has increased for 14 consecutive quarters, with growth averaging 42.2% over the last eight quarters.
  • The fastest year-over-year change in Operating Expenses over five years came in Q3 2021 (growth of 216.3%), and the weakest in Q4 2022 (a decline of 22.7%).
  • Business Quant data shows DYN's Operating Expenses at $125.28 million (Q1 2026), $116.13 million (Q4 2025) and $113.89 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Dyne Therapeutics 2.71 Bn 2.71 Bn - 181.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 181.66 Mn
Mar 31, 2026 125.28 Mn
Dec 31, 2025 116.13 Mn
Sep 30, 2025 113.89 Mn
Jun 30, 2025 115.79 Mn
Mar 31, 2025 122.37 Mn
Dec 31, 2024 97.11 Mn
Sep 30, 2024 105.66 Mn
Jun 30, 2024 71.96 Mn
Mar 31, 2024 69.16 Mn
Dec 31, 2023 67.69 Mn
Sep 30, 2023 62.27 Mn
Jun 30, 2023 66.74 Mn
Mar 31, 2023 45.46 Mn
Dec 31, 2022 40.15 Mn
Sep 30, 2022 42.28 Mn
Jun 30, 2022 52.76 Mn
Mar 31, 2022 35.78 Mn
Dec 31, 2021 51.96 Mn
Sep 30, 2021 42.77 Mn
API Access

Dyne Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=DYN&period=max&api_key=YOUR_API_KEY